A roundup of the week’s most newsworthy health industry press releases from PR Newswire, including the FDA’s approval of OTC Naloxone nasal spray. NEW YORK, March 31, 2023 /PRNewswire/ — With thousands of press releases published each week, it can be difficult to keep up with everything…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.